The possible hyperplastic effect on the mouse gastric mucosa following administration of 500 mg/kg of ebrotidine for 18 mo was investigated. The animals were taken from the study of carcinogenesis in mouse carried out with this product. Two different aspects were considered to assess such a possible hyperplastic effect. The height of the fundic and antral mucosa was microscopically measured in several points. Histologic sections obtained from standardized levels of the stomach were used. The density of argyrophil cells in the gastric mucosa has been also quantified, in order to identify enterochromaffin-like (ECL) cells, the most abundant among the cells that have this property. Grimelius' silver staining method was used to identify ECL cells. The cell count was performed under &times;400 magnification, and the length of mucosa examined was determined by computer-assisted image analysis. This study complements the mouse carcinogenesis study, in which no differences in tumor incidence were found between treated and control animals. The results show that administration of 500 mg/kg/day of ebrotidine for 18 mo to mice did not induce any hyperplastic effect on the gastric mucosa comprising its various cell types or any specific, diffuse, or focal hyperplasia of ECL cells.
INTRODUCTION
Ebrotidine is a new gastric acid secretion inhibitor by competitive antagonism of H, receptors. Efficacy has been demonstrated both in laboratory animals and in humans (1, 18) . In addition, ebrotidine has significant gastroprotective effect (15, 21, 22, 29) and the ability to interfere with the lipolytic and proteolytic enzymes of Helicobacter pylori (28) . The fact that ebrotidine is a competitive antisecretory drug, as shown directly in the isolated guinea-pig atrium in the histamine-induced positive inotropism test, is particularly important. This mechanism is the primary factor in attenuating the hyperplastic effects in gastric enteroendocrine cells, which are a result of the hypergastrinemia produced when the inhibition is irreversible or has an excessive duration. Unsurmountable H2 blockaders have been reported to cause carcinomatous lesions (4, 14, 24, 25, 30, 31) (3, 27) .
Upon completing the mouse carcinogenesis study with ebrotidine (26) , whose results showed an absence of carcinogenic risk in this species, the present complementary study was performed. The folds, resulting in an overall thickness greater than the rest of the normal fundus, it has been necessary to measure both regions separately. One of the aspects that has been considered most important is the standardization and correct orientation of the regions examined. In addition to the fundus, the height of the antrum was also measured, recording the maximum and minimum heights due to the progressive decrease in thickness from the cardias to the pylorus. According to this methodology, 4 heights have been obtained from the measurement of each stomach sample.
The examination has been carried out at a magnification of X20 using a calibrated eyepiece.
b. Quantification of ECL Cells: Using the correctly oriented sections, an ECL cell count was performed under a light microscope at a magnification of X400 in those mucosal segments where the entire gland was visible. The total number of fields studied was very high and fully representative of each study group (Table I) . Table III provides the data concerning cell density and also the actual length of mucosa studied. The length of gastric mucosa required to calculate cell density was measured on the same silver-stained sections using the MIP-3 image analysis system (MICROM ESPANA S.A.). A fifth area has also been considered corresponding to the antral region.
On the basis of the information obtained from the cell counts and the length of mucosa examined, the mean argyrophil cell density has been calculated for each region and for each study group.
Statistical Analysis. The data were analyzed statistically using the SPSS/PC+ 5.0 software package (19, 20) . The mucosa heights and cell densities between the different study groups were compared by variance analysis (ANOVA), using a 2-factor model (sex and experimental group) with interaction. The level of significance was set at a = 0.05. Table II shows the means and confidence intervals of each of the animal groups and gastric regions assessed. No significant differences were observed neither in the males nor in the females between the control group and the group treated with 500 mg/kg of ebrotidine. This lack of difference refers to both height increases and decreases.
RESULTS

Study of Gastric Mucosa Thickness
Study of ECL Cell Density Table III shows the mean density obtained for each sex and experimental group in the various types of fundus considered in the prior classification of the gastric mucosa and the density obtained ion the antral area of the stomach.
To give an idea of the representativeness of the density results shown in Table III , the total length of correctly oriented mucosa for performing the cell count has also been included.
As was to be expected from the literature and the results of previous studies (9) , in which the absence of ECL cells in the antrum was shown by immunohistochemical methods, the density of marked cells in the antrum was considerably less than that found in the fundus. The cells detected in the antrum correspond to the enteroendocrine type known as enterochromaffin cells.
These are also argyrophil cells and, therefore, are stained by the same method. Consequently, the antral cell density has not been taken into account in the calculations of total ECL cell densities.
In the regions classified as normal fundus and transitional fundus, no significant between-treatment group or between-sex differences have been found (Figs. 2, 3) .
In the mouse carcinogenesis study with ebrotidine (26) , it was stated that gastric mucosa adenomatous hyperplasia was found in several animals, both in those treated with 500 mg/kg of ebrotidine and in the controls, (Figs. 4, 5 ). In the fundic region affected by this change, the treated group differed significantly from the control group, although the differences are due to a decrease in cell density and not to an increase.
In the fundus with secondary folds, the significant differences are due to the differing behavior of the sexes depending on the treatment group. While the females in the control group tend to have higher densities than the males, in the treated group, the females' densities tend to be lower.
Upon considering the entire fundic region, the behavior of both sexes within each treatment group is the same, although the density obtained in the treatment group is significantly less than that of the control group.
In the antral region, the values obtained fail to show any significant differences either between the 2 study groups or between the sexes, although the mean cell densities are somewhat lower in the females.
DISCUSSION
In the last 10 yr, a large number of studies have been carried out in which the relationship among acid inhibition, hypergastrinemia, and enterocrine cell proliferation seems to be confirmed. The most widely accepted sequence of causes-effect is the following: prolonged acid secretion inhibition -sustained hypergastrinemia -diffuse ECL cell hyperplasia ~ focal ECL cell hyperplasia -~ ECL cell carcinoids. It seems clear that the cell hyperplasia-inducing effect is due to the trophic effect caused by hypergastrinemia (23) , as both the administration of exogenous gastrin (6, 14) and various diseases that cause hypergastrinemia in the absence of achlorhydria-such as nonantral atrophic gastritis, Zollinger-Ellison's syndrome, or other nonantral gastrinomas-also induce the hyperplastic effect (5, 11) . The association between hypergastrinemia and hyperplasia and/or gastric carcinoma also seems to be confirmed in humans (11, 12) .
A large number of investigators base the intensity and duration of the hypergastrinemia on the way in which the receptor has been blocked: either by an unsurmountable, noncompetitive mechanism or by a surmountable or competitive mechanism.
Indeed, there is no question about the importance of the surmountability of the blockade, as all the carcinogenesis studies published on unsurmountable H2 receptor inhibitors show that they cause oxyntic mucosa hyperplasia and carcinoids, consisting mostly of ECL cells (3, 4, 14, 31 
